Androgens regulate the immune/inflammatory response and cell survival pathways in rat ventral prostate epithelial cells

Endocrinology

Volumn 147, Issue 1, 2006, Pages 257-271

  Asirvatham, A J ^a   Schmidt, M ^a   Gao, B ^a   Chaudhary, J ^a,b  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b CLARK ATLANTA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CYTOKINE; INTERFERON; METRIBOLONE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CLUSTER ANALYSIS; CONTROLLED STUDY; DEVICE; DOWN REGULATION; DRUG MECHANISM; GENE EXPRESSION; HORMONE ACTION; IMMUNE RESPONSE; INFLAMMATION; MALE; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE EPITHELIUM; PROSTATE VENTRAL LOBE; PURIFICATION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TIME; UNINDEXED SEQUENCE; UPREGULATION;

ANDROGENS; ANIMALS; CELL CULTURE TECHNIQUES; CELL SURVIVAL; EPITHELIAL CELLS; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; METRIBOLONE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 29344441929     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0942     Document Type: Article

References (81)

1. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y 1987 The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362
2. Marker PC, Donjacour AA, Dahiya R, Cunha GR 2003 Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253:165-174
3. Abate-Shen C, Shen MM 2000 Molecular genetics of prostate cancer. Genes Dev 14:2410-2434
4. Heinlein CA, Chang C 2004 Androgen receptor in prostate cancer. Endocr Rev 25:276-308
5. Prins GS, Birch L, Greene GL 1991 Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129:3187-3199
6. Lee DK, Chang C 2003 Molecular communication between androgen receptor and general transcription machinery. J Steroid Biochem Mol Biol 84:41-49
7. Heinlein CA, Chang C 2002 Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175-200
8. Heinlein CA, Chang C 2002 The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol Endocrinol 16:2181-2187
9. Kyprianou N, Isaacs JT 1988 Activation of programmed cell death in the rat ventral prostate after castration. Endocrinology 122:552-562
10. Kwong J, Choi HL, Huang Y, Chan FL 1999 Ultrastructural and biochemical observations on the early changes in apoptotic epithelial cells of the rat prostate induced by castration. Cell Tissue Res 298:123-136
11. Banerjee S, Banerjee PP, Brown TR 2000 Castration-induced apoptotic cell death in the Brown Norway rat prostate decreases as a function of age. Endocrinology 141:821-832
12. Evans GS, Chandler JA 1987 Cell proliferation studies in the rat prostate. II. The effects of castration and androgen-induced regeneration upon basal and secretory cell proliferation. Prostate 11:339-351
13. Pang ST, Dillner K, Wu X, Pousette A, Norstedt G, Flores-Morales A 2002 Gene expression profiling of androgen deficiency predicts a pathway of prostate apoptosis that involves genes related to oxidative stress. Endocrinology 143:4897-4906
14. Desai KV, Michalowska AM, Kondaiah P, Ward JM, Shih JH, Green JE 2004 Gene expression profiling identifies a unique androgen-mediated inflammatory/immune signature and a PTEN (phosphatase and tensin homolog deleted on chromosome 10)-mediated apoptotic response specific to the rat ventral prostate. Mol Endocrinol 18:2895-2907
15. Wang Z, Tufts R, Haleem R, Cai X 1997 Genes regulated by androgen in the rat ventral prostate. Proc Natl Acad Sci USA 94:12999-13004
16. Furuya Y, Isaacs JT 1993 Differential gene regulation during programmed death (apoptosis) versus proliferation of prostatic glandular cells induced by androgen manipulation. Endocrinology 133:2660-2666
17. Nantermet PV, Xu J, Yu Y, Hodor P, Holder D, Adamski S, Gentile MA, Kimmel DB, Harada S, Gerhold D, Freedman LP, Ray WJ 2004 Identification of genetic pathways activated by the androgen receptor during the induction of proliferation in the ventral prostate gland. J Biol Chem 279:1310-1322
18. Jiang F, Wang Z 2003 Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray. Endocrinology 144:1257-1265
19. Porkka KP, Visakorpi T 2001 Detection of differentially expressed genes in prostate cancer by combining suppression subtractive hybridization and cDNA library array. J Pathol 193:73-79
20. De Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, Isaacs WB, Nelson WG 2003 Human prostate cancer precursors and pathobiology. Urology 62:55-62
21. Okada H, Tsubura A, Okamura A, Senzaki H, Naka Y, Komatz Y, Morii S 1992 Keratin profiles in normal/hyperplastic prostates and prostate carcinoma. Virchows Arch A Pathol Anat Histopathol 421:157-161
22. Stanbrough M, Leav I, Kwan PW, Bubley GJ, Balk SP 2001 Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium. Proc Natl Acad Sci USA 98:10823-10828
23. Eng MH, Charles LG, Ross BD, Chrisp CE, Pienta KJ, Greenberg MN, Hsu CX, Sanda MG 1999 Early castration reduces prostatic carcinogenesis in transgenic mice. Urology 54:1112-1119
24. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin B 2002 The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA 99:11890-11895
25. Velasco AM, Gillis KA, Li Y, Brown EL, Sadler TM, Achilleos M, Greenberger LM, Frost P, Bai W, Zhang Y 2004 Identification and validation of novel androgen-regulated genes in prostate cancer. Endocrinology 145:3913-3924
26. Oosterhoff JK, Grootegoed JA, Blok LJ 2005 Expression profiling of androgen-dependent and -independent LNCaP cells: EGF versus androgen signalling. Endocr Relat Cancer 12:135-148
27. DePrimo SE, Diehn M, Nelson JB, Reiter RE, Matese J, Fero M, Tibshirani R, Brown PO, Brooks JD 2002 Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3:RESEARCH0032
28. Shou J, Soriano R, Hayward SW, Cunha GR, Williams PM, Gao WQ 2002 Expression profiling of a human cell line model of prostatic cancer reveals a direct involvement of interferon signaling in prostate tumor progression. Proc Natl Acad Sci USA 99:2830-2835
29. Amler LC, Agus DB, LeDuc C, Sapinoso ML, Fox WD, Kern S, Lee D, Wang V, Leysens M, Higgins B, Martin J, Gerald W, Dracopoli N, Cordon-Cardo C, Scher HI, Hampton GM 2000 Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model CWR22-R1. Cancer Res 60:6134-6141
30. Xu LL, Su YP, Labiche R, Segawa T, Shanmugam MN, McLeod DG, Moul JW, Srivastava S 2001 Quantitative expression profile of androgen-regulated genes in prostate cancer cells and identification of prostate-specific genes. Int J Cancer 92:322-328
31. Fujimoto N, Suzuki T, Honda H, Kitamura S 2004 Estrogen enhancement of androgen-responsive gene expression in hormone-induced hyperplasia in the ventral prostate of F344 rats. Cancer Sci 95:711-725
32. Homma Y, Kondo Y, Kaneko M, Kitamura T, Nyou WT, Yanagisawa M, Yamamoto Y, Kakizoe T 2004 Promotion of carcinogenesis and oxidative stress by dietary cholesterol in rat prostate. Carcinogenesis 25:1011-1014
33. Rhim JS 2003 Research into molecular and genetic mechanisms underlying prostate carcinogenesis would be greatly advanced by in vitro prostate cell models. Drugs Today 39:837-847
34. Cussenot O, Berthon P, Cochand-Priollet B, Maitland NJ, Le Duc A 1994 Immunocytochemical comparison of cultured normal epithelial prostatic cells with prostatic tissue sections. Exp Cell Res 214:83-92
35. Ilio KY, Sensibar JA, Lee C 1995 Effect of TGF-β1, TGF-α, and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture. J Androl 16:482-490
36. Chaudhary J, Schmidt M, Sadler-Riggleman I 2005 Negative acting HLH proteins Id1, Id2, Id3, and Id4 are expressed in prostate epithelial cells. Prostate 64:253-264
37. Hill CM, Anway MD, Zirkin BR, Brown TR 2004 Intratesticular androgen levels, androgen receptor localization, and androgen receptor expression in adult rat Sertoli cells. Biol Reprod 71:1348-1358
38. Li Y, Friel PJ, Robinson MO, McLean DJ, Griswold MD 2002 Identification and characterization of testis- and epididymis-specific genes: cystatin SC and cystatin TE-1. Biol Reprod 67:1872-1880
39. Moeller H, Blank B, Lander K, Mates G 1987 Ontogeny of the androgen receptor in rat ventral prostate during sexual development. Res Exp Med (Berl) 187:287-294
40. Chopra DP, Grignon DJ, Joiakim A, Mathieu PA, Mohamed M, Sakr WA, Powell IJ, Sarkar FH 1996 Differential growth factor responses of epithelial cell cultures derived from normal human prostate, benign prostatic hyperplasia, and primary prostate carcinoma. J Cell Physiol 169:269-280
41. Chaproniere DM, McKeehan WL 1986 Serial culture of single adult human prostatic epithelial cells in serum-free medium containing low calcium and a new growth factor from bovine brain. Cancer Res 46:819-824
42. Chowdhury A, Harber GJ, Chopra DP 1989 Characterization and serial propagation of mouse prostate epithelial cells in serum-free medium. Biol Cell 67:281-287
43. Gnanapragasam VJ, Robson CN, Neal DE, Leung HY 2002 Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Oncogene 21:5069-5080
44. Yan G, Fukabori Y, Nikolaropoulos S, Wang F, McKeehan WL 1992 Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial- cell andromedin. Mol Endocrinol 6:2123-2128
45. Kasai S, Sugimura K, Matsumoto K, Nishi N, Kishimoto T, Nakamura T 1996 Hepatocyte growth factor is a paracrine regulator of rat prostate epithelial growth. Biochem Biophys Res Commun 228:646-652
46. Peehl DM 2005 Primary cell cultures as models of prostate cancer development. Endocr Relat Cancer 12:19-47
47. Krongrad A, Wilson CM, Wilson JD, Allman DR, McPhaul MJ 1991 Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells. Mol Cell Endocrinol 76:79-88
48. Claessens F, Celis L, Peeters B, Heyns W, Verhoeven G, Rombauts W 1989 Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding protein. Biochem Biophys Res Commun 164:833-840
49. Arnold JT, Le H, McFann KK, Blackman MR 2005 Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells. Am J Physiol 288:E573-E584
50. Chen Q, Kaji H, Kanatani M, Sugimoto T, Chihara K 2004 Testosterone increases osteoprotegerin mRNA expression in mouse osteoblast cells. Horm Metab Res 36:674-678
51. Lu S, Tsai SY, Tsai MJ 1997 Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res 57:4511-4516
52. Pewitt EB, Haleem R, Wang Z 1999 Adrenomedullin gene is abundantly expressed and directly regulated by androgen in the rat ventral prostate. Endocrinology 140:2382-2386
53. Yang G, Gregory CW, Shang Q, O'Brien DA, Zhang YL 2001 Differential expression of CCAAT/enhancer-binding protein-δ (c/EBPδ) in rat androgendependent tissues and human prostate cancer. J Androl 22:471-480
54. Yang SZ, Abdulkadir SA 2003 Early growth response gene 1 modulates androgen receptor signaling in prostate carcinoma cells. J Biol Chem 278:39906-39911
55. Castoria G, Lombardi M, Barone MV, Bilancio A, Di Domenico M, Bottero D, Vitale F, Migliaccio A, Auricchio F 2003 Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 161:547-556
56. Moore MG, Wetterau LA, Francis MJ, Peehl DM, Cohen P 2003 Novel stimulatory role for insulin-like growth factor binding protein-2 in prostate cancer cells. Int J Cancer 105:14-19
57. Rajah R, Valentinis B, Cohen P 1997 Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 272:12181-12188
58. Brigstock DR 2003 The CCN family: a new stimulus package. J Endocrinol 178:169-175
59. Yardy GW, Brewster SF 2005 Wnt signalling and prostate cancer. Prostate Cancer Prostatic Dis 8:119-126
60. Holen I, Croucher PI, Hamdy FC, Eaton CL 2002 Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells. Cancer Res 62:1619-1623
61. Pearce JJ, Penny G, Rossant J 1999 A mouse cerberus/Dan-related gene family. Dev Biol 209:98-110
62. Thomas R, Anderson WA, Raman V, Reddi AH 1998 Androgen-dependent gene expression of bone morphogenetic protein 7 in mouse prostate. Prostate 37:236-245
63. Levedakou EN, Strohmeyer TG, Effert PJ, Liu ET 1992 Expression of the matrix Gla protein in urogenital malignancies. Int J Cancer 52:534-537
64. Sandhu C, Peehl DM, Slingerland J 2000 p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells. Cancer Res 60:2616-2622
65. Isaacs JT, Furuya Y, Berges R 1994 The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. Semin Cancer Biol 5:391-400
66. Hoffman GE, Smith MS, Verbalis JG 1993 c-Fos and related immediate early gene products as markers of activity in neuroendocrine systems. Front Neuroendocrinol 14:173-213
67. Nagpal ML, Chen Y, Lin T 2004 Effects of overexpression of CXCL10 (cytokine-responsive gene-2) on MA-10 mouse Leydig tumor cell steroidogenesis and proliferation. J Endocrinol 183:585-594
68. Barila D, Plateroti M, Nobili F, Muda AO, Xie Y, Morimoto T, Perozzi G 1996 The Dri 42 gene, whose expression is up-regulated during epithelial differentiation, encodes a novel endoplasmic reticulum resident transmembrane protein. J Biol Chem 271:29928-29936
69. Sahu A, Lambris JD 2001 Structure and biology of complement protein C3, a connecting link between innate and acquired immunity. Immunol Rev 180:35-48
70. Cutolo M, Sulli A, Capellino S, Villaggio B, Montagna P, Seriolo B, Straub RH 2004 Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 13:635-638
71. Culig Z, Klocker H, Bartsch G, Hobisch A 2002 Androgen receptors in prostate cancer. Endocr Relat Cancer 9:155-170
72. Sanford DC, DeWille JW 2005 C/EBPδ is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells. Prostate 63:143-154
73. Spiotto MT, Chung TD 2000 STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate 42:88-98
74. Lou W, Ni Z, Dyer K, Tweardy DJ, Gao AC 2000 Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway. Prostate 42:239-242
75. Okamoto M, Webber MM, Quader S, Oyasu R 1998 Interleukin-6 and epidermal growth factor promote anchorage-independent growth of immortalized human prostatic epithelial cells treated with N-methyl-N-nitrosourea. Prostate 35:255-262
76. Kip1, a cyclin-dependent kinase inhibitor, and neuronlike morphology in LNCaP prostate tumor cells. Biochem Biophys Res Commun 257:609-614
77. Lee SO, Lou W, Hou M, de Miguel F, Gerber L, Gao AC 2003 Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clin Cancer Res 9:370-376
78. Hobisch A, Eder IE, Putz T, Hominger W, Bartsch G, Klocker H, Culig Z 1998 Interleukin-6 regulates prostate-specific protein expression in prostate carcinoma cells by activation of the androgen receptor. Cancer Res 58:4640-4645
79. Zerbini LF, Wang Y, Cho JY, Libermann TA 2003 Constitutive activation of nuclear factor κB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer. Cancer Res 63:2206-2215
80. Thiel G, Cibelli G 2002 Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 193:287-292
81. Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola D 2003 Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes. J Biol Chem 278:11802-11810